Current Portfolio
eTheRNA
mRNA immunotherapies for oncology and infectious diseases.
Key Facts
- Sector
Life Sciences
- Country
Belgium
- Fund
LSP 5
- Entry
2016
Website
Do You Want to Know More?
We are eager to explore how we can achieve great things together.